دورية أكاديمية
أعرض في EDS

Synergic Role of Dietary Bioactive Compounds in Breast Cancer Chemoprevention and Combination Therapies.

التفاصيل البيبلوغرافية
العنوان: Synergic Role of Dietary Bioactive Compounds in Breast Cancer Chemoprevention and Combination Therapies.
المؤلفون: Mecca M; Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Rionero in Vulture, Italy., Sichetti M; Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Rionero in Vulture, Italy., Giuseffi M; Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Rionero in Vulture, Italy., Giglio E; Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Rionero in Vulture, Italy., Sabato C; Laboratory of Preclinical and Translational Research, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Rionero in Vulture, Italy., Sanseverino F; Unit of Gynecologic Oncology, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Rionero in Vulture, Italy., Marino G; Unit of Breast Cancer, Centro di Riferimento Oncologico della Basilicata (IRCCS-CROB), 85028 Rionero in Vulture, Italy.
المصدر: Nutrients [Nutrients] 2024 Jun 14; Vol. 16 (12). Date of Electronic Publication: 2024 Jun 14.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Publishing Country of Publication: Switzerland NLM ID: 101521595 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6643 (Electronic) Linking ISSN: 20726643 NLM ISO Abbreviation: Nutrients Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI Publishing
مواضيع طبية MeSH: Breast Neoplasms*/prevention & control , Phytochemicals*/pharmacology , Phytochemicals*/administration & dosage, Humans ; Female ; Diet ; Chemoprevention/methods ; Drug Synergism ; Animals ; Antineoplastic Combined Chemotherapy Protocols ; Glucosinolates/pharmacology ; Glucosinolates/therapeutic use ; Glucosinolates/administration & dosage
مستخلص: Breast cancer is the most common tumor in women. Chemotherapy is the gold standard for cancer treatment; however, severe side effects and tumor resistance are the major obstacles to chemotherapy success. Numerous dietary components and phytochemicals have been found to inhibit the molecular and signaling pathways associated with different stages of breast cancer development. In particular, this review is focused on the antitumor effects of PUFAs, dietary enzymes, and glucosinolates against breast cancer. The major databases were consulted to search in vitro and preclinical studies; only those with solid scientific evidence and reporting protective effects on breast cancer treatment were included. A consistent number of studies highlighted that dietary components and phytochemicals can have remarkable therapeutic effects as single agents or in combination with other anticancer agents, administered at different concentrations and via different routes of administration. These provide a natural strategy for chemoprevention, reduce the risk of breast cancer recurrence, impair cell proliferation and viability, and induce apoptosis. Some of these bioactive compounds of dietary origin, however, show poor solubility and low bioavailability; hence, encapsulation in nanoformulations are promising tools able to increase clinical efficiency.
References: Mol Cancer Ther. 2002 Nov;1(13):1161-72. (PMID: 12479697)
ACS Nano. 2019 Nov 26;13(11):13445-13455. (PMID: 31670945)
Chem Res Toxicol. 1992 Mar-Apr;5(2):188-93. (PMID: 1643248)
Eur J Pharmacol. 2018 May 15;827:125-148. (PMID: 29535002)
Natl Toxicol Program Tech Rep Ser. 2017 Jul;(584):. (PMID: 33540959)
Cancer Prev Res (Phila). 2018 Aug;11(8):451-464. (PMID: 29764806)
Nutrients. 2021 Jul 26;13(8):. (PMID: 34444715)
Biochimie. 2020 Dec;179:217-227. (PMID: 33098909)
Annu Rev Entomol. 2009;54:57-83. (PMID: 18811249)
Biochem Pharmacol. 2009 Mar 15;77(6):937-46. (PMID: 19022225)
J Surg Res. 2017 Jul;215:34-46. (PMID: 28688659)
Food Chem. 2013 Aug 15;139(1-4):224-30. (PMID: 23561099)
J Nutr Biochem. 2012 May;23(5):452-7. (PMID: 21684140)
Clin Immunol. 2002 Aug;104(2):183-90. (PMID: 12165279)
Expert Opin Biol Ther. 2022 May;22(5):615-625. (PMID: 35176951)
Anticancer Res. 2020 Jul;40(7):3669-3683. (PMID: 32620606)
Carcinogenesis. 2002 Aug;23(8):1297-305. (PMID: 12151347)
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2477-81. (PMID: 17164373)
Br J Cancer. 1994 Aug;70(2):219-27. (PMID: 8054269)
J Nutr. 2003 Jul;133(7 Suppl):2448S-2455S. (PMID: 12840223)
Nutr Cancer. 2003;45(1):101-12. (PMID: 12791510)
Curr Opin Clin Nutr Metab Care. 2007 Mar;10(2):123-8. (PMID: 17284998)
Biomed Pharmacother. 2009 Jul;63(6):429-35. (PMID: 19553068)
Molecules. 2023 Jan 16;28(2):. (PMID: 36677944)
J Cancer. 2016 Jun 23;7(10):1281-94. (PMID: 27390604)
Int J Mol Sci. 2023 Apr 06;24(7):. (PMID: 37047814)
Mol Carcinog. 2016 May;55(5):486-98. (PMID: 25789847)
Front Oncol. 2023 Jan 09;12:1068778. (PMID: 36698404)
Pharm Res. 2017 Feb;34(2):438-452. (PMID: 27981451)
J Nutr. 2005 Sep;135(9):2124-9. (PMID: 16140887)
Epidemiology. 2012 Mar;23(2):320-7. (PMID: 22317813)
Biotechnol Res Int. 2012;2012:976203. (PMID: 23304525)
Br J Nutr. 2012 Jun;107 Suppl 2:S228-39. (PMID: 22591896)
J Nutr Biochem. 2018 May;55:12-25. (PMID: 29331880)
J Med Food. 2012 Apr;15(4):344-9. (PMID: 22191568)
J Nanobiotechnology. 2018 Sep 19;16(1):71. (PMID: 30231877)
Pharm Res. 2014 Aug;31(8):1882-92. (PMID: 24522814)
Nutrients. 2019 Jul 03;11(7):. (PMID: 31277273)
Mo Med. 2012 Mar-Apr;109(2):142-5. (PMID: 22675796)
Maturitas. 2010 Sep;67(1):25-8. (PMID: 20493648)
J Oral Maxillofac Pathol. 2020 May-Aug;24(2):405. (PMID: 33456268)
Toxicol Appl Pharmacol. 2022 Jan 15;435:115853. (PMID: 34973289)
Chem Biol Interact. 2018 Jun 25;290:19-36. (PMID: 29775573)
Ann Oncol. 2003 Jul;14(7):1051-6. (PMID: 12853346)
Biochim Open. 2018 Jun 11;7:1-9. (PMID: 30003042)
Oncogene. 2005 Mar 31;24(14):2343-53. (PMID: 15735741)
Medicina (Kaunas). 2022 Oct 01;58(10):. (PMID: 36295538)
Br J Cancer. 2009 Dec 15;101(12):1978-85. (PMID: 19920822)
Neoplasma. 2009;56(6):548-56. (PMID: 19728765)
Eur J Cancer. 2009 Aug;45(12):2077-86. (PMID: 19493674)
Anticancer Res. 2004 Jan-Feb;24(1):133-7. (PMID: 15015587)
Eur J Cancer Prev. 2005 Jun;14(3):263-70. (PMID: 15901996)
Nutrients. 2020 May 27;12(6):. (PMID: 32471217)
Biochimie. 2014 Jan;96:22-7. (PMID: 24012777)
Br J Cancer. 2013 Feb 19;108(3):486-92. (PMID: 23299528)
Oncol Rep. 2007 Apr;17(4):713-9. (PMID: 17342305)
Heliyon. 2023 Dec 10;10(1):e23553. (PMID: 38187226)
Nutrients. 2023 Mar 29;15(7):. (PMID: 37049508)
Nutr Cancer. 2019;71(6):992-1006. (PMID: 31032639)
Life (Basel). 2021 Apr 06;11(4):. (PMID: 33917319)
Anticancer Res. 2010 Sep;30(9):3381-90. (PMID: 20944112)
Nutr Cancer. 2000;38(2):168-78. (PMID: 11525594)
Biochem Biophys Res Commun. 1996 Nov 1;228(1):153-8. (PMID: 8912651)
Appl Biochem Biotechnol. 2020 Dec;192(4):1208-1223. (PMID: 32710170)
Biomed Pharmacother. 2002 Oct;56(8):365-79. (PMID: 12442909)
Prog Lipid Res. 2010 Jan;49(1):76-86. (PMID: 19715726)
Biochem Biophys Rep. 2023 Jun 01;35:101492. (PMID: 37304131)
Br J Nutr. 2002 Apr;87(4):281-9. (PMID: 12064337)
Exp Gerontol. 2023 Apr;174:112121. (PMID: 36792040)
EPMA J. 2022 Apr 14;13(2):315-334. (PMID: 35437454)
Front Pharmacol. 2021 Feb 26;11:632079. (PMID: 33716731)
BMC Cancer. 2014 Feb 18;14:105. (PMID: 24548731)
Biol Pharm Bull. 2021;44(4):571-578. (PMID: 33790107)
Biotechnol Prog. 2016 Jan-Feb;32(1):5-13. (PMID: 26518672)
J Natl Cancer Inst. 1995 Apr 19;87(8):587-92. (PMID: 7752256)
Mol Cell Biochem. 2021 Feb;476(2):525-533. (PMID: 33064289)
Anticancer Agents Med Chem. 2021;21(18):2466-2477. (PMID: 33372884)
Integr Cancer Ther. 2021 Jan-Dec;20:15347354211060369. (PMID: 34825602)
Obes Res. 2002 Jun;10(6):518-25. (PMID: 12055328)
Int Immunopharmacol. 2009 Mar;9(3):340-6. (PMID: 19162239)
J Pers Med. 2022 Jan 12;12(1):. (PMID: 35055410)
Mol Nutr Food Res. 2014 Oct;58(10):1991-2000. (PMID: 24975513)
Chin Med. 2016 Nov 15;11:46. (PMID: 27891174)
Foods. 2021 Nov 24;10(12):. (PMID: 34945460)
PLoS One. 2010 Apr 22;5(4):e10296. (PMID: 20421971)
Prostaglandins Leukot Essent Fatty Acids. 2009 Aug-Sep;81(2-3):187-91. (PMID: 19502020)
Nutrients. 2019 Apr 26;11(5):. (PMID: 31035457)
J Biomed Nanotechnol. 2014 Dec;10(12):3558-75. (PMID: 26000370)
Cancer Lett. 2008 Jun 28;265(1):113-23. (PMID: 18378071)
J Neuroinflammation. 2020 Nov 3;17(1):327. (PMID: 33143743)
J Med Signals Sens. 2019 Oct 24;9(4):267-273. (PMID: 31737556)
Mol Cancer. 2015 Sep 17;14:172. (PMID: 26377202)
J Biol Chem. 2001 Jun 22;276(25):22332-40. (PMID: 11297539)
Br J Nutr. 2012 Jun;107 Suppl 2:S171-84. (PMID: 22591891)
Nanotechnology. 2020 Apr 10;31(15):155101. (PMID: 31846941)
J Agric Food Chem. 2008 Nov 26;56(22):10505-9. (PMID: 18950181)
Mol Imaging Biol. 2018 Jun;20(3):437-447. (PMID: 29043471)
Carcinogenesis. 2012 Oct;33(10):1897-908. (PMID: 22678116)
Clin Immunol. 2008 Jul;128(1):66-74. (PMID: 18482869)
J Nutr Biochem. 2002 Dec;13(12):711-716. (PMID: 12550055)
Curr Cancer Drug Targets. 2008 May;8(3):187-98. (PMID: 18473732)
Foods. 2021 Sep 23;10(10):. (PMID: 34681298)
Int J Nanomedicine. 2023 Jul 28;18:4275-4311. (PMID: 37534056)
Int J Cancer. 2011 Oct 1;129(7):1781-91. (PMID: 21154750)
Cancers (Basel). 2021 Apr 27;13(9):. (PMID: 33925607)
Nutrients. 2014 Nov 18;6(11):5184-223. (PMID: 25412153)
Carcinogenesis. 2007 Apr;28(4):809-15. (PMID: 17052999)
Hum Exp Toxicol. 2019 Jan;38(1):136-147. (PMID: 29992829)
Food Funct. 2023 Sep 19;14(18):8101-8128. (PMID: 37650738)
Exp Cell Res. 2021 Jul 15;404(2):112638. (PMID: 34015312)
Cancer Res. 2005 Jan 1;65(1):364-71. (PMID: 15665315)
Int J Mol Sci. 2023 Feb 11;24(4):. (PMID: 36835056)
Int J Biochem Cell Biol. 2006 Feb;38(2):196-208. (PMID: 16194618)
Biofactors. 2010 Nov-Dec;36(6):474-82. (PMID: 20848558)
Immunol Invest. 2008;37(4):263-77. (PMID: 18569070)
Theranostics. 2021 Aug 11;11(18):8797-8812. (PMID: 34522212)
Ann N Y Acad Sci. 2004 Dec;1030:361-8. (PMID: 15659818)
Cell Immunol. 2001 May 25;210(1):66-75. (PMID: 11485354)
Heart. 2012 Nov;98(22):1620-5. (PMID: 22760864)
Immunol Cell Biol. 2023 Oct;101(9):805-828. (PMID: 37650498)
Carcinogenesis. 1998 Sep;19(9):1631-9. (PMID: 9771935)
Nutr Cancer. 2020;72(5):835-848. (PMID: 31474154)
PLoS One. 2015 Nov 02;10(11):e0140963. (PMID: 26524341)
Biomed Res Int. 2015;2015:137097. (PMID: 26339588)
Cancer Lett. 2008 Apr 18;262(2):153-63. (PMID: 18314259)
Cancer Prev Res (Phila). 2019 Mar;12(3):147-158. (PMID: 30679159)
Cancer Res. 2006 May 1;66(9):4880-7. (PMID: 16651444)
Curr Biol. 2020 Aug 17;30(16):R921-R925. (PMID: 32810447)
Mol Nutr Food Res. 2015 Mar;59(3):424-33. (PMID: 25522265)
J Sci Food Agric. 2017 Mar;97(5):1386-1395. (PMID: 27790704)
J Med Food. 2019 Feb;22(2):121-126. (PMID: 30372361)
Mol Carcinog. 2015 Sep;54(9):810-20. (PMID: 24729481)
Nutr Cancer. 2004;48(1):84-94. (PMID: 15203382)
Mol Cell Biochem. 2011 Dec;358(1-2):345-54. (PMID: 21761201)
World J Clin Oncol. 2014 Aug 10;5(3):412-24. (PMID: 25114856)
Carcinogenesis. 2010 Sep;31(9):1523-30. (PMID: 20525880)
Nutrients. 2021 Nov 29;13(12):. (PMID: 34959865)
Cell Cycle. 2014;13(16):2587-99. (PMID: 25486199)
Oncol Lett. 2017 Jun;13(6):4427-4432. (PMID: 28599444)
Biomed Res Int. 2018 Nov 29;2018:7970618. (PMID: 30627573)
Adv Nutr. 2012 Jul 01;3(4):506-16. (PMID: 22797986)
Cancer Lett. 2020 Nov 28;493:189-196. (PMID: 32891712)
Cancer Lett. 2010 Apr 28;290(2):148-56. (PMID: 19700238)
Food Sci Nutr. 2020 Sep 09;8(10):5673-5682. (PMID: 33133569)
Cancer Res. 1999 Mar 15;59(6):1244-51. (PMID: 10096555)
Biochem Pharmacol. 1988 Jan 15;37(2):333-8. (PMID: 3342090)
Biomed Pharmacother. 2023 May;161:114490. (PMID: 36931031)
Biomed Pharmacother. 2020 Jan;121:109635. (PMID: 31739165)
Molecules. 2019 Oct 06;24(19):. (PMID: 31590459)
Cancers (Basel). 2020 Nov 05;12(11):. (PMID: 33167363)
Theranostics. 2017 Aug 15;7(14):3461-3477. (PMID: 28912888)
Immunity. 2019 Jul 16;51(1):27-41. (PMID: 31315034)
Front Oncol. 2023 Jan 27;13:1099811. (PMID: 36776289)
Biochem Pharmacol. 2002 Mar 15;63(6):1085-97. (PMID: 11931841)
Cancer. 2015 Jul 1;121(13):2244-52. (PMID: 25809414)
Front Nutr. 2021 Oct 01;8:734334. (PMID: 34660663)
Eur J Clin Nutr. 2012 Aug;66(8):878-84. (PMID: 22669332)
Oxid Med Cell Longev. 2018 Jun 6;2018:5438179. (PMID: 29977456)
J Nutr Biochem. 2013 Mar;24(3):505-15. (PMID: 22749134)
Nutr Cancer. 2023;75(3):980-991. (PMID: 36542459)
Acta Pharmacol Sin. 2009 May;30(5):501-12. (PMID: 19417730)
Biomed Rep. 2016 Sep;5(3):283-288. (PMID: 27602208)
Clin Cancer Res. 2006 Oct 1;12(19):5879-86. (PMID: 17020996)
Heliyon. 2022 Feb 17;8(2):e08989. (PMID: 35243102)
Cureus. 2022 Aug 11;14(8):e27876. (PMID: 36110474)
Asian Pac J Cancer Prev. 2014 Jan;14(11):6709-14. (PMID: 24377593)
Anticancer Res. 2011 Nov;31(11):3733-7. (PMID: 22110194)
In Vivo. 2019 Jul-Aug;33(4):983-997. (PMID: 31280187)
Adv Exp Med Biol. 2020;1260:1-12. (PMID: 32304028)
Biochim Biophys Acta. 2012 Dec;1826(2):370-84. (PMID: 22750268)
Molecules. 2018 Nov 15;23(11):. (PMID: 30445746)
Mol Nutr Food Res. 2010 Oct;54(10):1414-21. (PMID: 20425756)
Annu Rev Food Sci Technol. 2023 Mar 27;14:347-366. (PMID: 36972159)
Annu Rev Plant Biol. 2006;57:303-33. (PMID: 16669764)
J Surg Res. 2016 Jul;204(1):47-54. (PMID: 27451867)
Front Pharmacol. 2020 Jan 28;10:1614. (PMID: 32116665)
Nutrients. 2021 Aug 10;13(8):. (PMID: 34444909)
Mol Nutr Food Res. 2010 Mar;54(3):415-25. (PMID: 19904759)
Hum Exp Toxicol. 2021 May;40(5):812-825. (PMID: 33118390)
Int J Breast Cancer. 2012;2012:712536. (PMID: 22811918)
Cancer Lett. 2009 Sep 18;282(2):167-76. (PMID: 19339108)
Int J Nanomedicine. 2021 Oct 27;16:7269-7281. (PMID: 34737564)
J Nutr. 2011 Feb;141(2):201-6. (PMID: 21178081)
Brain Behav Immun. 2020 Nov;90:108-137. (PMID: 32800927)
Breast Cancer. 2019 Jul;26(4):499-509. (PMID: 30684233)
Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:279-286. (PMID: 28254296)
Toxicol Lett. 2001 Mar 31;120(1-3):1-7. (PMID: 11323156)
PLoS One. 2010 Jul 06;5(7):e11457. (PMID: 20625516)
J Biol Chem. 1998 Feb 13;273(7):3838-47. (PMID: 9461564)
Biomed Res Int. 2013;2013:310186. (PMID: 23762838)
معلومات مُعتمدة: Ricerca Corrente Ministero della Salute
فهرسة مساهمة: Keywords: PUFA; breast cancer; bromelain; cancer prevention; diet; glucosinolates; isothiocyanate; phytochemicals
المشرفين على المادة: 0 (Phytochemicals)
0 (Glucosinolates)
تواريخ الأحداث: Date Created: 20240627 Date Completed: 20240627 Latest Revision: 20240629
رمز التحديث: 20240629
مُعرف محوري في PubMed: PMC11206589
DOI: 10.3390/nu16121883
PMID: 38931238
قاعدة البيانات: MEDLINE
الوصف
تدمد:2072-6643
DOI:10.3390/nu16121883